Design, synthesis, and biological evaluation of 1,3-dioxoisoindoline-5-carboxamide derivatives as T-type calcium channel blockers.

[1]  H. Rhim,et al.  Synthesis and SAR studies of a novel series of T-type calcium channel blockers. , 2006, Bioorganic & medicinal chemistry.

[2]  J. McGivern.  Targeting N-type and T-type calcium channels for the treatment of pain. , 2006, Drug discovery today.

[3]  Kozo Yao,et al.  Pharmacological, pharmacokinetic, and clinical properties of benidipine hydrochloride, a novel, long-acting calcium channel blocker. , 2006, Journal of pharmacological sciences.

[4]  Sheryl E. Koch,et al.  The L-type calcium channel in the heart: the beat goes on. , 2005, The Journal of clinical investigation.

[5]  M. Barton,et al.  The antihyperalgesic effects of the T-type calcium channel blockers ethosuximide, trimethadione, and mibefradil. , 2005, European journal of pharmacology.

[6]  K. Hidaka,et al.  Subtype switching of T-type Ca 2+ channels from Cav3.2 to Cav3.1 during differentiation of embryonic stem cells to cardiac cell lineage. , 2005, Circulation journal : official journal of the Japanese Circulation Society.

[7]  H. Rhim,et al.  T-type calcium channel trigger p21ras signaling pathway to ERK in Cav3.1-expressed HEK293 cells , 2005, Brain Research.

[8]  Channy Park,et al.  Protective effect of T-type calcium channel blocker flunarizine on cisplatin-induced death of auditory cells , 2005, Hearing Research.

[9]  H. Rhim,et al.  Synthesis and biological activity of 3,4-dihydroquinazolines for selective T-type Ca2+ channel blockers. , 2005, Bioorganic & medicinal chemistry letters.

[10]  S. Flatters.  T-type calcium channels: a potential target for the treatment of chronic pain , 2005 .

[11]  K. Shigenobu,et al.  Pathophysiological significance of T-type Ca2+ channels: T-type Ca2+ channels and drug development. , 2005, Journal of pharmacological sciences.

[12]  S. Nah,et al.  The biochemical activation of T-type Ca2+ channels in HEK293 cells stably expressing alpha1G and Kir2.1 subunits. , 2004, Biochemical and biophysical research communications.

[13]  M. Doddareddy,et al.  Synthesis and biological evaluation of novel T-type Ca2+ channel blockers. , 2004, Bioorganic & medicinal chemistry.

[14]  T. Macdonald,et al.  Design, synthesis, and biological evaluation of novel T-Type calcium channel antagonists. , 2004, Bioorganic & medicinal chemistry letters.

[15]  G. Bennett,et al.  Ethosuximide reverses paclitaxel- and vincristine-induced painful peripheral neuropathy , 2004, Pain.

[16]  M. Doddareddy,et al.  3D QSAR studies on T-type calcium channel blockers using CoMFA and CoMSIA. , 2004, Bioorganic & medicinal chemistry.

[17]  M. Doddareddy,et al.  First pharmacophoric hypothesis for T-type calcium channel blockers. , 2004, Bioorganic & medicinal chemistry.

[18]  K. Elmslie.  Calcium channel blockers in the treatment of disease , 2004, Journal of neuroscience research.

[19]  Daesoo Kim,et al.  Thalamic Control of Visceral Nociception Mediated by T-Type Ca2+ Channels , 2003, Science.

[20]  F. Porreca,et al.  Reversal of experimental neuropathic pain by T-type calcium channel blockers , 2003, Pain.

[21]  Aaron M. Beedle,et al.  Synthesis and evaluation of a new class of nifedipine analogs with T-type calcium channel blocking activity. , 2002, Molecular pharmacology.

[22]  A. Kochegarov.  Therapeutical application of voltage-gated calcium channel modulators , 2002 .

[23]  A. Dickenson,et al.  Effects of ethosuximide, a T-type Ca(2+) channel blocker, on dorsal horn neuronal responses in rats. , 2001, European journal of pharmacology.

[24]  H. Schaible,et al.  Effects of antagonists to high-threshold calcium channels upon spinal mechanisms of pain, hyperalgesia and allodynia , 2000, Pain.

[25]  B. Bean,et al.  Mibefradil inhibition of T-type calcium channels in cerebellar purkinje neurons. , 1998, Molecular pharmacology.

[26]  R. Sorelle.  Withdrawal of Posicor from market. , 1998, Circulation.

[27]  C. Giordano.  Society for biomolecular screening , 1996 .

[28]  S. Mishra,et al.  Selective inhibition of T-type Ca2+ channels by Ro 40-5967. , 1994, Circulation research.

[29]  D. Prince,et al.  Differential effects of petit mal anticonvulsants and convulsants on thalamic neurones: calcium current reduction , 1990, British journal of pharmacology.

[30]  D. Prince,et al.  Characterization of ethosuximide reduction of low‐threshold calcium current in thalamic neurons , 1989, Annals of neurology.